<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03151889</url>
  </required_header>
  <id_info>
    <org_study_id>TENS-HIR 2017</org_study_id>
    <nct_id>NCT03151889</nct_id>
  </id_info>
  <brief_title>Eletric Stimulation for Hipossalivation Induced by Radiotherapy</brief_title>
  <acronym>TENS_HIR</acronym>
  <official_title>Transcutaneous Electric Nerve Stimulation (TENS) Treatment for Hipossalivation Induced by Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Health Science of Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Irmandade Santa Casa de Misericórdia de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of Health Science of Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, cancer is a disease of high incidence, already considered a public health problem.
      Among the most prevalent are head and neck neoplasms, and depending on the location and
      extent of the lesion, the treatments are surgery, chemotherapy and / or radiotherapy that
      have a great impact on the quality of life. Radiation therapy is a frequently chosen
      treatment, and depending on the dose of radiation, causes changes such as hyposalivation.
      There are techniques for salivary flow stimulation, however, most of the options involve the
      use of medications, which limits administration to part of the patients. Transcutaneous
      electric nerve stimulation (TENS) is an alternative that has been used to stimulate salivary
      flow, however there is a limited number of studies that have tested this technique after
      radiotherapy. The aim of this study was to verify the effect of TENS in increasing the
      salivary flow of individuals receiving radiotherapy to treat tumors of the head and neck. The
      sample will have 80 patients randomly divided into two groups: TENS group and Control group.
      In both groups, a quality of life questionnaire (UW-QOL) will be applied and a
      speech-language assessment will be performed. The hypothesis of this research is that TENS is
      effective in increasing the amount of saliva. Secondary outcomes involve the evaluation of
      the effect of this technique on the quality of life, mainly in the questions: speech,
      chewing, saliva and deglutition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The sample will have 80 patients randomly divided into two groups: 1) TENS group; 2) control
      group. A quality of life questionnaire (UW-QOL) will be applied and a speech-language
      assessment will be performed. The hypothesis of this research is that TENS increasing the
      amount of saliva. Secondary outcomes involve the evaluation of the effect of this technique
      on the quality of life, mainly in the questions: speech, chewing, saliva and deglutition.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 30, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2017</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Salivary Flow</measure>
    <time_frame>five minutes</time_frame>
    <description>Salivary flow per minute (ml)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>30 days</time_frame>
    <description>qqv University Washington</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hyposalivation</condition>
  <condition>Electric Stimulation Therapy</condition>
  <condition>Head and Neck Neoplasm</condition>
  <condition>Radiotherapy</condition>
  <arm_group>
    <arm_group_label>TENS Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TENS Group: Pre-test evaluations (Clinic Conditions; Live Quality; Salivary Flux); TENS treatments (50Hz / pulse duration of 250 ms / high intensities tolerated / continuously for 20 minutes / 2 sessions a week / 4 weeks / total of the 8 TENS sessions) and Post-test evaluations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control Group: Pre-test evaluations (Clinic Conditions; Live Quality; Salivary Flux) and Post-test evaluations.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TENS</intervention_name>
    <description>TENS Group: Pre-test evaluations (Clinic Conditions; Live Quality; Salivary Flux); TENS treatments (50Hz / pulse duration of 250 ms / high intensities tolerated / continuously for 20 minutes / 2 sessions a week / 4 weeks / total of the 8 TENS sessions) and Post-test evaluations.</description>
    <arm_group_label>TENS Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Starts radiotherapy treatment without previous hipossalivation

        The inclusion criteria according to information contained in electronic medical records and
        referred by the participants are:

          -  Patients undergoing oncological follow-up for the treatment of head and neck cancer at
             Santa Rita Hospital through radiotherapy;

          -  Have completed radiotherapy for at least 90 days;

          -  Do not present a history of carcinogenic lesion in the salivary glands (sublingual,
             submandibular and parotid);

          -  Do not present oral history of oral cancer;

          -  Have not undergone cervical emptying level I;

        Exclusion Criteria:

        Intolerance to the TENS

        The exclusion criteria are:

          -  No xerostomia;

             • Severe dysphagia;

          -  Stimulated salivary flow volume greater than 1.5 ml / minute;

          -  Use of glandular protective substances or salivary stimulants during the period of
             data collection;

          -  Use of a pacemaker or any other device that prevents electrical stimulation;

          -  Being pregnant;

          -  Unavailability of time to participate in the study (2x / week for one month);

          -  Excessive absences during treatment (&gt; 30% of total sessions).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Santos FB, Vasconcelos-Raposo JJ, Figueiredo Mdo C. Correlation between symptoms and course duration of upper aerodigestive tract cancer at early and advanced stages. Braz J Otorhinolaryngol. 2013 Nov-Dec;79(6):673-80. doi: 10.5935/1808-8694.20130125. English, Portuguese.</citation>
    <PMID>24474477</PMID>
  </results_reference>
  <results_reference>
    <citation>Langendijk JA. New developments in radiotherapy of head and neck cancer: higher precision with less patient discomfort? Radiother Oncol. 2007 Oct;85(1):1-6. Epub 2007 Sep 12.</citation>
    <PMID>17854932</PMID>
  </results_reference>
  <results_reference>
    <citation>Longman LP, McCracken CF, Higham SM, Field EA. The clinical assessment of oral dryness is a significant predictor of salivary gland hypofunction. Oral Dis. 2000 Nov;6(6):366-70.</citation>
    <PMID>11355268</PMID>
  </results_reference>
  <results_reference>
    <citation>Malpani BL, Jaiswar RK, Samuel AM. Noninvasive scintigraphic method to quantify unstimulated secretions from individual salivary glands. Auris Nasus Larynx. 1999 Oct;26(4):453-6.</citation>
    <PMID>10530742</PMID>
  </results_reference>
  <results_reference>
    <citation>Andrews N, Griffiths C. Dental complications of head and neck radiotherapy: Part 1. Aust Dent J. 2001 Jun;46(2):88-94. Review.</citation>
    <PMID>11491236</PMID>
  </results_reference>
  <results_reference>
    <citation>Alajbeg I, Falcão DP, Tran SD, Martín-Granizo R, Lafaurie GI, Matranga D, Pejda S, Vuletić L, Mantilla R, Leal SC, Bezerra AC, Ménard HA, Kimoto S, Pan S, Maniegas L, Krushinski CA, Melilli D, Campisi G, Paderni C, Mendoza GR, Yepes JF, Lindh L, Koray M, Mumcu G, Elad S, Zeevi I, Barrios BC, López Sánchez RM, Lassauzay C, Fromentin O, Beiski BZ, Strietzel FP, Konttinen YT, Wolff A, Zunt SL. Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Jun;113(6):773-81. doi: 10.1016/j.oooo.2012.01.012.</citation>
    <PMID>22668705</PMID>
  </results_reference>
  <results_reference>
    <citation>Almeida JP, Kowalski LP. Pilocarpine used to treat xerostomia in patients submitted to radioactive iodine therapy: a pilot study. Braz J Otorhinolaryngol. 2010 Sep-Oct;76(5):659-62. English, Portuguese.</citation>
    <PMID>20963353</PMID>
  </results_reference>
  <results_reference>
    <citation>Lakshman AR, Babu GS, Rao S. Evaluation of effect of transcutaneous electrical nerve stimulation on salivary flow rate in radiation induced xerostomia patients: a pilot study. J Cancer Res Ther. 2015 Jan-Mar;11(1):229-33. doi: 10.4103/0973-1482.138008.</citation>
    <PMID>25879367</PMID>
  </results_reference>
  <results_reference>
    <citation>Strietzel FP, Lafaurie GI, Mendoza GR, Alajbeg I, Pejda S, Vuletić L, Mantilla R, Falcão DP, Leal SC, Bezerra AC, Tran SD, Ménard HA, Kimoto S, Pan S, Martín-Granizo RA, Lozano ML, Zunt SL, Krushinski CA, Melilli D, Campisi G, Paderni C, Dolce S, Yepes JF, Lindh L, Koray M, Mumcu G, Elad S, Zeevi I, Barrios BC, López Sánchez RM, Beiski BZ, Wolff A, Konttinen YT. Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial. Arthritis Rheum. 2011 Jan;63(1):180-90. doi: 10.1002/art.27766.</citation>
    <PMID>20882668</PMID>
  </results_reference>
  <results_reference>
    <citation>Dawes C, Cross HG, Baker CG, Chebib FS. The influence of gland size on the flow rate and composition of human parotid saliva. Dent J. 1978 Jan;44(1):21-5.</citation>
    <PMID>272988</PMID>
  </results_reference>
  <results_reference>
    <citation>Hargitai IA, Sherman RG, Strother JM. The effects of electrostimulation on parotid saliva flow: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Mar;99(3):316-20.</citation>
    <PMID>15716838</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 11, 2017</study_first_submitted>
  <study_first_submitted_qc>May 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2017</study_first_posted>
  <last_update_submitted>July 21, 2017</last_update_submitted>
  <last_update_submitted_qc>July 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Health Science of Porto Alegre</investigator_affiliation>
    <investigator_full_name>Fabrício Edler Macagnan</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

